18 Aug 2021 --- Chr. Hansen has reached a settlement with Glycom over several human milk oligosaccharides (HMO) production patent disputes. These include litigations in Denmark inherited from Chr. Hansen’s acquisition of Jennewein Biotechnologie. As part of the settlement, Chr. Hansen and Glycom have agreed on royalty-bearing patent licenses. The parties have agreed to disclose no further details of the settlement agreement and declined to comment to NutritionInsight.
.png)
